Global Med Technologies(R), Inc.'s Inlog Subsidiary Licenses Its Leading Laboratory Information System to Gabriel Martin Hospital of Saint-Paul de ...(fdonor center and transfusion management...),Health
Navigation Links
Global Med Technologies(R), Inc.'s Inlog Subsidiary Licenses Its Leading Laboratory Information System to Gabriel Martin Hospital of Saint-Paul de la Reunion
Date:11/6/2008
f donor center and transfusion management systems as well as cellular therapy software, laboratory information systems and quality assurance medical software systems internationally. Inlog's products include EdgeBlood*, EdgeTrack*, EdgeCell, EdgeLab and SAPANET.
Global Med's U.S. division, eDonor(R), provides a web-based donor relationship management system that integrates recruitment, scheduling, retention and fulfillment for national as well as local community blood centers and hospitals. eDonor's products and services are designed to complement Global Med's strong line of international blood management and laboratory information software and service solutions.
Global Med's U.S. subsidiary, PeopleMed(R), Inc., provides cost-effective customized software validation, consulting and compliance solutions to hospitals and donor centers.
For more information about Global Med's products and services, please call 800-996-3428 or visit http://www.globalmedtech.com, http://www.peoplemed.com, http://www.inlog.com, http://www.eDonor.com, and http://www.wyndgate.com.
*FDA 510(k) clearance required prior to sales in the U.S.
Agfa and ORBIS(TM) are trademarks of Agfa Gevaert N.V., Belgium, or its subsidiaries.
This news release may include statements that constitute
forward-looking statements, usually containing the words "believe,"
"estimate," "project," "expects" or similar expressions. These statements
are made pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. Forward-looking statements inherently
involve risks and uncertainties that could cause actual results to differ
materially from the forward-looking statements. By making thes
'/>"/>
| SOURCE Global Med Technologies, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. Corbett Selected to Host the Only Midwest Global Awards Judging Competition
2. Tata Consultancy Services to Support Roches Global Capacity Building Initiative
3. Creative Technology Services Enhances its Global Competitiveness with Additional Regulatory Certifications
4. Briefing on a new Web resource to address global drinking water crisis
5. MDS Pharma Services Wins Award for Management of Global Malaria Trial
6. Neusoft Becomes First Global Growth Company Partner of World Economic Forum
7. Resonant Medical Appoints New Vice President of Global Sales
8. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
9. The era of global aging: GSAs annual meeting to present new research on hot topics in aging
10. MEDEX Global Group & Harvard Medical International Join Forces to Create the Most Comprehensive Health Information Resource for International Travelers
11. Ultrasonix Adds Global Medical Imaging Into Its North American Sales Force
Post Your Comments:
(Date:12/4/2009).... 4 , ,What: Humana ( ht... health benefits provider, is introd...s.com ), a senior-friendly dance pad, ...ues., Dec. 8 at 1 p.m. The festive ...n to the public, will feature Dancetown, ...
(Date:12/4/2009)...PRNewswire-FirstCall/ -- MedClean Technologies, In...Company has entered into a preferred stock purchas...ware limited liability company, doing business as... to the Purchase Agreement, MedClean will receive ...agreed to sell up to 750 shares of its Series C Pr...
(Date:12/4/2009)...Newswire/ -- PLUS Diagnostics announced today th...y services with the launch of a national hematolog... company,s expansion from a regional laboratory to...ering diagnostic services across a full range of s... now hematology/oncology. ,, PLUS Diagnostics ...
(Date:12/4/2009)...RNewswire-FirstCall/ -- PD-Rx Pharmaceuticals, Inc...5,012,334 for the first quarter ended September 30...ear. Operating income and net income for the quar...a 70% decrease over the same period last year. ,... sector sales. This trend is expected to continue...
(Date:12/4/2009)...swire/ -- The National Cancer Institute has awarde...Hutchinson Cancer Research Center to become the na...vice Contact Center. ,, The move will create 60...ng the size of its current CIS workforce - once th...is scheduled for March 15, 2010. The Seattle CIS c...
Breaking Medicine News(10 mins):Health News:Humana Launches Dancetown on Tues., Dec. 8 in Kissimmee 2Health News:MedClean Technologies Enters Into Preferred Stock Agreement of Up to $7.5 Million 2Health News:MedClean Technologies Enters Into Preferred Stock Agreement of Up to $7.5 Million 3Health News:PLUS Diagnostics Launches Hematology/Oncology Diagnostic Services 2Health News:PLUS Diagnostics Launches Hematology/Oncology Diagnostic Services 3Health News:PD-Rx Pharmaceuticals, Inc. Reports 1st Quarter Earnings 2Health News:Hutchinson Center Wins $55.4 Million Contract to Become Sole Operator of the NCI Cancer Information Service 2[0] Humana Launches Dancetown on Tues., Dec. 8 in Kissimmee[0] MedClean Technologies Enters Into Preferred Stock Agreement of Up to $7.5 Million[0] PLUS Diagnostics Launches Hematology/Oncology Diagnostic Services[0] PD-Rx Pharmaceuticals, Inc. Reports 1st Quarter Earnings[0] Hutchinson Center Wins $55.4 Million Contract to Become Sole Operator of the NCI Cancer Information Service
... Madhya Pradesh may raise the retirement age of me... doctors posted in interior areas// in order to pr...etter health and medical services to people is a p...ce will also be provided to them," Chief Minister ...
... Dubai: With a motive of enabling women the best p...s about to commence a free breast cancer screening...
The tests will enable all women in the emirate, U...ter treatment outcomes.
Dr Hajer Al Hosani,...
... AMA President, Dr Mukesh Haikerwal, said today th...rocesses for assessing the skills// and experience... confidence in the quality of medicine in Australi... and fair to ensure the community gets expert medi...
... American scientists have identified a single prot... the development of diabetes//.
Researchers at...calcineurin, is vital to the proper functioning of...0 genes that had already been linked to diabetes. ...
... According to a study conducted at the University ...evelopment of chronic pain following breast cancer...ve surgery, and severe post-operative pain.
...ths, near the breast, next to armpit and in the up...
... A team of scientists from Bristol University has ...e energy levels in living heart cells that will ai...rt attack.
The scientists expect this techni... Chemistry.
Dr Elinor Griffiths and her team...
Other Medicine News:Health News:Consistent National Standards For Assessment Of Overseas Trained Doctors A Priority 2Health News:Post-Operative Pain in Breast Cancer Surgery 2Health News:A glowing energy measure for heart cells 2Madhya Pradesh to Raise the Retirement Age of Specialist Medicos'Dubai to commence free breast cancer screeningConsistent National Standards For Assessment Of Overseas Trained Doctors A PriorityDiabetes Protein Identified by U.S. ScientistsPost-Operative Pain in Breast Cancer SurgeryA glowing energy measure for heart cells
(Date:12/3/2009)...c. 3 Radiology imaging leader MEDR...ration capabilities at the November 2009 Radiology...t.PACS(TM) product, enabling the first radiology ...t release in the company,s newly branded Certegra...://www.newscom.com/cgi-bin/prnh/20091203/NE20631 ...
(Date:12/3/2009).... 3 Wound Management...rapidly growing provider of specialty medical prod... Industry Representative Association (HIRA) to ser...ing representative to market the company,s core Ce...IRA will market and sell Wound Management Technolo...
(Date:12/3/2009)...re-FirstCall/ -- Cardium Therapeutics (NYSE Amex: ...diary, Tissue Repair Company, submitted a 510(k) p...d Drug Administration (FDA) seeking marketing clea...sed on positive data from the Company,s recently c...submission with the FDA covers Excellagen XL(TM) ...
Breaking Medicine Technology:MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 2MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 3Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 2Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 3Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 2Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 3Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 4Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 5Sigma Aldrich Acquires ChemNavigator Inc to Provide Researchers With Industry Leading Chemical Compound Selection and Procurement Services 13431 1Sigma Aldrich Acquires ChemNavigator Inc to Provide Researchers With Industry Leading Chemical Compound Selection and Procurement Services 13431 2Sigma Aldrich Acquires ChemNavigator Inc to Provide Researchers With Industry Leading Chemical Compound Selection and Procurement Services 13431 3SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 1SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 2SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 3SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 4SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 5SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 6SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 7SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 8SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 9SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 10Combo Treatment May Ease Depression After Stroke 53891 1Combo Treatment May Ease Depression After Stroke 53891 2[0] MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009[0] Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up[0] Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds
...ONTO, Feb. 15 A seven-year, international,study p...es such as,acupuncture, neck manipulation and mass...ck pain than many current practices. Also included...exercises, education, neck,mobilization, low level...h as neck collars and ultrasound are not recommend...
...TH SAN FRANCISCO, Calif., Feb. 15 Cell,Genesys, I...an analysis,examining the potential association be...rostate cancer and increased patient survival in a...e refractory prostate cancer,(HRPC). More than 400...were,identified in the sera of the treated patient...
Other Medicine Technology:Seven-Year Neck Pain Study Sheds Light on Best Care 2Seven-Year Neck Pain Study Sheds Light on Best Care 3Cell Genesys Reports Association Between Immune Response and Patient Survival in Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer 2Cell Genesys Reports Association Between Immune Response and Patient Survival in Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer 3Cell Genesys Reports Association Between Immune Response and Patient Survival in Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer 4Cell Genesys Reports Association Between Immune Response and Patient Survival in Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer 5| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |